Respected outpatient provider chooses Visage 7 for their Deconstructed PACS strategy
SAN DIEGO, CA, January 12, 2015 – Visage Imaging Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), announced today the signing of a five-year contract with Zwanger-Pesiri Radiology (“Zwanger-Pesiri”) – a highly respected radiology group and outpatient imaging provider on New York’s Long Island. Visage 7 enables enterprise imaging with amazingly fast, thin-client, server-side processing technology, as well as simple mobile access to imaging results via Visage EaseSM.
The group will use the Visage 7 Enterprise Imaging Platform as the core component of its Deconstructed PACSSM enterprise imaging strategy enabling the group to provide exceptionally fast, state-of-the-art imaging to their reading radiologists and referring physicians. Visage 7 will integrate to Zwanger-Pesiri’s existing vendor neutral archive and enterprise workflow engine. Complementing the Visage 7 enterprise viewer, Zwanger-Pesiri has selected the Primordial workflow orchestration platform, enabling highly sophisticated, seamless reading workflow across Zwanger-Pesiri’s distributed network.
Zwanger-Pesiri is one of the largest US providers of outpatient imaging services with 18 imaging centers and 58 radiologists, regionally distributed across Long Island. The group is known for acquiring the latest in advanced imaging technology being the first private radiology practice in the US to purchase a PET/MRI (positron emission tomography/magnetic resonance imaging) scanner. This is in addition to significant recent investments in 3D mammography or digital breast tomosynthesis (DBT) and other leading edge technologies.
“Based on the continued growth of the Zwanger-Pesiri imaging center network, and our strategic investment in the latest modalities, it was apparent that our legacy PACS could not keep up with our needs,” said Dr. Steven L. Mendelsohn, CEO. “We are committed to using the most advanced technology and did an extensive review of the available systems on the market. Once we experienced what Visage 7 offered, using our own studies across our own network, it was immediately clear that this was the system for us. We see our investment in Visage as a key enabler to our future growth.”
“This deal is strategic for us in many ways,” said Dr. Sam Hupert, CEO, Visage Imaging. “Not only does it provide us with a key reference account on the US East Coast, it will open up further opportunities for us in the large but fragmented US outpatient/imaging center market, a market currently undergoing a major wave of consolidation. It adds to the significant wins we have had in the US over the past 12 to 18 months confirming our view that unlike others, we can address the entire spectrum of radiology practices ranging from remote reading/teleradiology groups, outpatient imaging, all the way to some of the largest health systems in the country.”
*Visage Ease is not a medical device and must not be used for diagnosis.